A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes.

Trial Profile

A Phase III, Randomized, Double-Blind, Placebo-Controlled Evaluation of Pregabalin for Alleviating Hot Flashes.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Dec 2015

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Hot flashes
  • Focus Therapeutic Use
  • Acronyms N07C1
  • Most Recent Events

    • 03 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Dec 2009 Results were published in the Journal of Clinical Oncology.
    • 09 Nov 2009 Results published in the Journal of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top